InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
7%
T+90 mean return
-14.9%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Mack David Henry, Chief Executive Officer. Officer active across 1 company, notably PMV Pharmaceuticals, Inc.. In total, 18 filings have been published. Activity tracked since 20 May 2021. The latest transaction was filed on 3 December 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations18 total
91,750 shares@ US$0.5318.5% of flowCommon StockSEC:0001415889-25-001853:0
163,890 shares0Common StockSEC:0001209191-24-001993:0
198,407 shares@ US$0.5339.8% of flowCommon StockSEC:0001209191-23-054997:0
85,500 shares@ US$0.5316.4% of flowCommon StockSEC:0001209191-23-045010:0
33,000 shares@ US$0.530.024% mcap26.2% of flowCommon StockSEC:0001209191-22-026341:0
20,000 shares@ US$1.370.037% mcap39.8% of flowCommon StockSEC:0001209191-22-017591:0
40,000 shares0Common StockSEC:0001209191-21-070116
40,000 shares0Common StockSEC:0001209191-21-070116:0
5,500 shares@ US$0.530.0036% mcap3.9% of flowCommon StockSEC:0001209191-21-052787:0
5,500 shares@ US$0.531.0% of flowCommon StockSEC:0001209191-21-052787
1,029 shares@ US$0.530.2% of flowCommon StockSEC:0001209191-21-047745
1,029 shares@ US$0.530.0007% mcap0.7% of flowCommon StockSEC:0001209191-21-047745:0
204 shares@ US$0.530.0% of flowCommon StockSEC:0001209191-21-043738
204 shares@ US$0.530.0001% mcap0.1% of flowCommon StockSEC:0001209191-21-043738:0
10,000 shares@ US$0.530.0063% mcap6.8% of flowCommon StockSEC:0001209191-21-038419:0
10,000 shares@ US$0.531.7% of flowCommon StockSEC:0001209191-21-038419
7,793 shares@ US$0.535.3% of flowCommon StockSEC:0001209191-21-035364
7,793 shares@ US$0.530.0049% mcap5.3% of flowCommon StockSEC:0001209191-21-035364:0
18 of 18 declarations
About Mack David Henry
David Henry Mack is President and Chief Executive Officer at PMV Pharmaceuticals, Inc., a biopharmaceutical company focused on developing innovative treatments. In his role, he leads the company's strategy and oversees operations to ensure its success. His leadership is essential for PMV in its mission to improve patients' lives.
